Omitted Conflict of Interest Disclosures | JAMA Ophthalmology | JAMA Network
[Skip to Content]
[Skip to Content Landing]
Views 379
Citations 0
Correction
October 2018

Omitted Conflict of Interest Disclosures

JAMA Ophthalmol. 2018;136(10):1208. doi:10.1001/jamaophthalmol.2018.4285

In the Original Investigation titled “Congenital Retinal Macrovessel and the Association of Retinal Venous Malformations With Venous Malformations of the Brain,”1 published online March 1, 2018, and in the April 2018 issue of JAMA Ophthalmology, the authors disclosed conflicts of interest that were inadvertently omitted during the editing process. The Conflict of Interest Disclosures section should read as follows: “All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Freund has received personal fees from Heidelberg Engineering, Optos, and Optovue during the conduct of the study as well as from Spark Therapeutics and Genentech/Roche. Dr Choudhry has received nonfinancial research support from Topcon Medical Systems. Dr Arevalo has received nonfinancial support from EY Engineering; personal fees for consulting from Turing Pharmaceuticals, Second Sight Medical Products, Dutch Ophthalmic Research Center International, Allergan, and Bayer; and royalties from Springer. Dr Sarraf has received consultation fees from Amgen, Bayer, Genentech, Novartis, Nuvelution Pharmaceuticals, and Optovue; grants from Allergan, Genentech, Optovue, and Regeneron; and nonfinancial research support from Heidelberg Engineering and Optovue. No other disclosures were reported.” This article was corrected online.

References
1.
Pichi  F, Freund  KB, Ciardella  A,  et al.  Congenital retinal macrovessel and the association of retinal venous malformations with venous malformations of the brain.  JAMA Ophthalmol. 2018;136(4):372-379. doi:10.1001/jamaophthalmol.2018.0150PubMedGoogle ScholarCrossref
×